AAAAAA
Results:
1-17
|
Results: 17
Authors:
UBERTI JP
SILVER SM
ADAMS PT
JACOBSON P
SCALZO A
RATANATHARATHORN V
Citation: Jp. Uberti et al., TACROLIMUS AND METHOTREXATE FOR THE PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Bone marrow transplantation, 19(12), 1997, pp. 1233-1238
Authors:
JACOBSON PA
RATANATHARATHORN V
MA M
SCALZO A
WAGNER L
SCHORK MA
SILVER SM
ADAMS PT
UBERTI JP
Citation: Pa. Jacobson et al., ASSOCIATION OF WHOLE-BLOOD TACROLIMUS (TCL) LEVELS WITH ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) AND NEPHROTOXICITY IN ALLOGENEIC MARROW OR BLOOD STEM-CELL TRANSPLANT RECIPIENTS, Blood, 90(10), 1997, pp. 4410-4410
Authors:
JACOBSON PA
RATANATHARATHORN V
WU Y
BAKER J
LEVINE J
SILVER SM
ADAMS PT
UBERTI JP
Citation: Pa. Jacobson et al., RISK-ADJUSTED DOSE SCHEDULE OF GANCICLOVIR IS EFFECTIVE FOR THE PREVENTION OF CYTOMEGALOVIRUS-INFECTION IN ALLOGENEIC STEM-CELL TRANSPLANT RECIPIENTS, Blood, 90(10), 1997, pp. 4411-4411
Authors:
UBERTI JP
ADAMS PT
SILVER SM
JACOBSON PM
SCALZO A
HAMMELEF K
AYASH L
RATANATHARATHORN V
Citation: Jp. Uberti et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (APBSCT) FOR HIGH-RISK HEMATOLOGIC MALIGNANCIES - THE EFFICACY OF TACROLIMUS (TCL) FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD), Blood, 90(10), 1997, pp. 4514-4514
Authors:
UBERTI JP
SILVER SM
ADAMS PT
SCALZO A
RATANATHARATHORN V
Citation: Jp. Uberti et al., PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE WITH TACROLIMUS IN PATIENTS RECEIVING ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (ALLOPBSCT), Blood, 88(10), 1996, pp. 3790-3790
Authors:
VARTERASIAN M
RATANATHARATHORN V
UBERTI JP
KARANES C
ABELLA E
MOMIN F
KASTENSPORTES C
ALKATIB A
LUM L
HEILBRUN LK
SENSENBRENNER LL
Citation: M. Varterasian et al., CLINICAL COURSE AND OUTCOME OF PATIENTS WITH HODGKINS-DISEASE WHO PROGRESS AFTER AUTOLOGOUS TRANSPLANTATION, Leukemia & lymphoma, 20(1-2), 1995, pp. 59-65
Authors:
TURKERI LN
LUM LG
UBERTI JP
ABELLA E
MOMIN F
KARANES C
SENSENBRENNER LL
HAAS GP
Citation: Ln. Turkeri et al., PREVENTION OF HEMORRHAGIC CYSTITIS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT PREPARATIVE REGIMENS WITH CYCLOPHOSPHAMIDE AND BUSULFAN - ROLE OF CONTINUOUS BLADDER IRRIGATION, The Journal of urology, 153(3), 1995, pp. 637-640
Authors:
UBERTI JP
RATANATHARATHORN V
KARANES C
SENSENBRENNER LL
Citation: Jp. Uberti et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Leukemia & lymphoma, 14(5-6), 1994, pp. 379-385
Authors:
SCHULTZ KR
RATANATHARATHORN V
ABELLA E
EISENBREY AB
KARANES C
LUM LG
DEPLANQUE MM
UBERTI JP
RAVINDRANATH Y
SENSENBRENNER LL
Citation: Kr. Schultz et al., GRAFT FAILURE IN CHILDREN RECEIVING HLA-MISMATCHED MARROW TRANSPLANTSWITH BUSULFAN-CONTAINING REGIMENS, Bone marrow transplantation, 13(6), 1994, pp. 817-822
Authors:
LUM LG
JOSHI ID
SMITH MR
RATANATHARATHORN V
GALOFORO SC
KARANES C
UBERTI JP
SENSENBRENNER LL
Citation: Lg. Lum et al., CONSTITUTIVE AND MITOGEN-STIMULATED CYTOKINE MESSENGER-RNA EXPRESSIONBY PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM MOST AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS IS INTACT, Bone marrow transplantation, 13(2), 1994, pp. 187-195
Authors:
UBERTI JP
JOSHI I
UEDA M
MARTILOTTI F
SENSENBRENNER LL
LUM LG
Citation: Jp. Uberti et al., PRECLINICAL STUDIES USING IMMOBILIZED OKT3 TO ACTIVATE HUMAN T-CELLS FOR ADOPTIVE IMMUNOTHERAPY - OPTIMAL CONDITIONS FOR THE PROLIFERATION AND INDUCTION OF NON-MHC-RESTRICTED CYTOTOXICITY, Clinical immunology and immunopathology, 70(3), 1994, pp. 234-240
PREPARATIVE REGIMES WITHOUT TOTAL-BODY IRRADIATION (TBI) IN THE RECIPIENTS OF UNRELATED DONOR MARROW
Authors:
RATANATHARATHORN V
KARANES C
MOMIN F
UBERTI JP
SENSENBRENNER LL
ABELLA E
LUM LG
Citation: V. Ratanatharathorn et al., PREPARATIVE REGIMES WITHOUT TOTAL-BODY IRRADIATION (TBI) IN THE RECIPIENTS OF UNRELATED DONOR MARROW, Blood, 84(10), 1994, pp. 10000342-10000342
Authors:
RATANATHARATHORN V
UBERTI JP
KARANES C
LUM LG
ABELLA E
SENSENBRENNER LL
Citation: V. Ratanatharathorn et al., BUSULFAN, ARA-C AND CYCLOPHOSPHAMIDE (BAC) AS PREPARATIVE REGIMEN FORALLOGENIC TRANSPLANTS IN HIGH-RISK MYELOID DISORDERS, Experimental hematology, 21(8), 1993, pp. 1132-1132
Authors:
LUM LG
JOSHI ID
GALOFORO SC
ABELLA E
KARANES C
RATANATHARATHORN V
SCHULTZ KR
UBERTI JP
SENSENBRENNER LL
LEDBETTER JA
JUNE CH
Citation: Lg. Lum et al., COACTIVATION WITH ANTI-CD28 MONOCLONAL-ANTIBODY ENHANCES ANTI-CD3 MONOCLONAL ANTIBODY-INDUCED PROLIFERATION AND IL-2 SYNTHESIS IN T-CELLS FROM AUTOLOGOUS BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 12(6), 1993, pp. 565-571
Authors:
UEDA M
JOSHI ID
DAN M
UBERTI JP
CHOU TH
SENSENBRENNER LL
LUM LG
Citation: M. Ueda et al., PRECLINICAL STUDIES FOR ADOPTIVE IMMUNOTHERAPY IN BONE-MARROW TRANSPLANTATION - GENERATION OF ANTI-CD3 ACTIVATED CYTOTOXIC T-CELLS FROM NORMAL DONORS AND AUTOLOGOUS BONE-MARROW TRANSPLANT CANDIDATES, Transplantation, 56(2), 1993, pp. 351-356
Authors:
KARANES C
UBERTI JP
RATANATHARATHORN V
LUM L
ABELLA E
MOMIN F
SENSENBRENNER L
Citation: C. Karanes et al., CYCLOPHOSPHAMIDE, VP-16, AND BCNU (CVB) FOR AUTOLOGOUS AND ALLOGENEICBONE-MARROW TRANSPLANTATION (BMT) IN NON-HODGKINS-LYMPHOMA (NHL), Blood, 82(10), 1993, pp. 10000144-10000144
Authors:
UBERTI JP
KARANES C
RATANATHARATHORN V
LUM L
ABELLA E
MOMIN F
SENSENBRENNER L
Citation: Jp. Uberti et al., BUSULFAN-BASED PREPARATIVE REGIMENS FOR ACUTE MYELOID-LEUKEMIA IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - THE ROLE OF HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) FOR HIGH-RISK PATIENTS, Blood, 82(10), 1993, pp. 10000643-10000643
Risultati:
1-17
|